Analysts liked what they saw in the ISRG Q1 earnings report and are issuing favorable revisions. The few tracked by Marketbeat.com include a single price target reduction to $440, which is well above the current action and the consensus. The range of new targets runs from a near-consensus of $375 to $436, assuming 1% to 18% of upside. The high end of the range was also set recently and adds another 600 bps of upside to the outlook. Analysts rate this stock at a consensus Moderate Buy and have been firm and steady in that view for more than twelve months.
Insider selling may be a headwind for the market. In Q1 2024, insiders sold en masse and may continue to sell as the share price advances. However, insiders own a tiny 0.90% of the company and participate in share-based compensation, so no significant red flags are raised, given the quality of the results. The institutions would be a more substantial concern; they own about 84% of the stock, but their activity is light and has helped support the market over the last year.
Intuitive Surgical’s stock price broke out to a new high recently and is now receding to retest for support at the critical level. Assuming the market takes advantage of the opportunity, ISRG stock should begin to rebound soon. The critical support target is near the previous highs at $358, which is only a short fall away. If the market doesn’t support this stock at $358, it could fall below the critical level and move as low as $300 before rebounding.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free ReportCompany | MarketRankâ„¢ | Current Price | Price Change | Dividend Yield | P/E Ratio | Consensus Rating | Consensus Price Target |
---|---|---|---|---|---|---|---|
Intuitive Surgical (ISRG) | 4.7095 of 5 stars | $512.64 | 0.1% | N/A | 75.17 | Moderate Buy | $592.86 |
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.
Start Your 30-Day Trial